Company Filing History:
Years Active: 2015-2018
Title: Innovations of Tomomi Furihata
Introduction
Tomomi Furihata is a notable inventor based in Chiba, Japan. He has made significant contributions to the field of cancer research through his innovative patents. With a total of 3 patents, Furihata is recognized for his work in developing novel tumor markers and methods for cancer detection.
Latest Patents
One of Furihata's latest patents focuses on an alternative splicing variant of OATP1B3 mRNA. The primary objective of this invention is to provide a novel tumor marker and its applications. This includes a method for measuring the tumor marker, a measurement kit, and methods for detecting cancer. The invention also encompasses a kit for cancer detection and a method for screening preventive and therapeutic agents for cancer, including a cancer vaccine. The measurement method involves analyzing mRNA with specific nucleotide sequences to differentiate between variants, which is crucial for cancer detection and treatment.
Career Highlights
Furihata is affiliated with Chiba University, where he conducts his research and development activities. His work has garnered attention for its potential impact on cancer diagnostics and therapeutics.
Collaborations
Some of his notable coworkers include Sayaka Matsumoto and Miki Nagai, who contribute to the collaborative efforts in his research projects.
Conclusion
Tomomi Furihata's innovative work in cancer research exemplifies the importance of advancements in medical technology. His patents not only provide new methods for cancer detection but also pave the way for future therapeutic developments.